Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable ...

20 October 2026 · By · Wire by Fusion42

Published

20 October 2026

Topic

opportunities

◆ Sectors

Pet Tech

◆ Geography

United States

◆ Source

Read at news.zoetis.com →

◆ Verified

Fusion42 · 20 October 2026 · Fusion42 review

Zoetis has received FDA approval for Convenia RTU for Dogs, a more concentrated injectable antibiotic treatment providing up to 14 days of effective therapy for bacterial skin infections in medium to large dogs, administered by veterinary professionals to improve compliance.

This Wire brief sits within Fusion42's coverage of Pet Tech.

◆ ◆ The Wire takeaway

You have a clearer path to vet adoption with a single-dose antibiotic that solves common compliance issues. Clinics can now offer an easier treatment option that reduces missed doses and antibiotic resistance risks.

◆ Coverage

1 source · 20 Oct 2026

◆ Related on Wire

◆ Topics

Pet Techfda-approvalveterinary-medicineantibiotic-complianceinjectable-treatmentzoetis